AMTecH was formed to design, create, and test -- both virtually and physically -- a wide variety of electromechanical and biomedical components, systems and processes. Currently, the group is working on projects ranging from printed circuit boards for automobiles and aircraft to replacement parts for damaged and failing human organs and tissue, says Tim Marler, AMTecH co-director.
"Electromechanical systems are one of two current branches of the AMTecHgroup," he says. "We want to simulate, analyze and test printed circuit boards and assemblies, because they are used in a wide range of products from missiles to power plants to cell phones. "The second branch of the group involves biomanufacturing and is led by my colleague and AMTecH co-director Ibrahim Ozbolat, assistant professor of mechanical and industrial engineering," says Marler. "The long-term goal of this branch is to create functioning human organs some five or 10 years from now. This is not far-fetched."
Using its facilities for engineering living tissue systems, the Biomanufacturing Laboratory at CCAD is working to develop and refine various 3D printing processes required for organ and tissue fabrication, Ozbolat says.
"One of the most promising research activities is bioprinting a glucose-sensitive pancreatic organ that can be grown in a lab and transplanted anywhere inside the body to regulate the glucose level of blood," says Ozbolat. He adds that the 3D printing, as well as virtual electronic manufacturing, being conducted at AMTecH are done nowhere else in Iowa.
In fact, the multi-arm bio printer being used in the lab is unique. Ozbolat and Howard Chen, a UI doctoral student in industrial engineering, designed it and Chen built it. It turns out that managing multiple arms without having them collide with one another is difficult enough that other printers used in other parts of the world avoid the problem by using simpler designs calling for single-arm printing. As Chen continues to refine his
11 people already started in trial atNYC site, son starts trial with first dosage on Oct 23. Dr. Landau reports no toxicity problems with the first 11 patients to this point. I know it is still early but sounds very promising.
BTW, he was accepted at the NYC site. I cannot get it to accept the URL but if you go to Clinical trials dot gov you can do a search for the trial
Phase I, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis. My son has Amyloidosis and on Friday got notice of acceptance. I bought this stock after it was spun off from ELN @ 6.24 because of this drug. It looks like this will be a big winner if drug works. This disease is a very debilitating disease with those who get it have usually very little chance of living more than 2yrs. Hope it can be successful for my sons sake. When I told his doctors about this trial they didn't know anything about it. They were excited about it after doing their research. I know the doctor I talked to was buying this stock and I believe its move up is because of passing the word around. Doctor actually thanked me for info because he said they don't ever get info about trials and he is a specialist on Amyloidosis at University of Pennsylvania. The only thing is that it will be another 3 to 4 years before trials end. Sorry I didn't buy more, never thought it would move up this quick. Good luck to all.
on march 29th they had an article to buy acad at $2.20, now 6 days later they are saying to dump. They work with the MM's and there has been to many buys, MM needs to cover his short position of all he sold and he wants a long position before MLV starts touting it. Even a con of a pre-market trade to sucker people into selling. I am a firm bleiver that the MM uses news to move stocks and articles like seeking alpha are used to drive the stocks the way they want.
The first form 4's were submitted with a mistake in the price of $1.18. The form 4a's were submitted to corrected the $1.18 error to $2.18. Once a form is submitted the only way to correct it is to amend it making the first form null and void.
I agree. Picked up some C @ $4.40 for the long haul. I'm not recommending but definitely a better chance over a few years. Government selling some of their shares off plus other news looked like a buy. Ready to buy more if goes lower, if doesn't am happy with what I have.
AMFI will declare bankruptcy just to settle out books(clean up lose ends) as all bank assets went with Harris. Due to the fact that they are not restructuring it is possible this stock will not trade again thus ending viability of stock. At which point it might never trade again. If never traded again and closing out under bankruptcy, stock will be declared valueless and can be written off as a loss(upon broker clearing it from your account). Same thing happens with short. If stock doesn't trade they will be able to claim their buy back as zero. But this only happens upon complete closeout, which in this case should be rather quick.
all thinking is right, just said different ways with same outcome. You are only taxed on what you withdraw whether you made or lost money witnin the account. No gains or losses mean anything up to time of withdrawal for tax purposes.
For tax purposes there are no gains or losses taxed in an IRA. In regular IRA you only pay tax when you withdraw the money as ordinary income. In roth IRA no tax gain or loss.
Where is this transparency in government that obama speaks of? Always learning after the fact government screws you. If you make money they over tax you, if you lose money they limit your lose. They steal many companies with nothing left for the shareholders who were the believers and backbone for the start of many companies. All the restrictions taken off buying a home back in 1992 lead to this as banks and mortgage lenders used ways to trap people who shouldn't even own homes. Their greed has now lead to their demise and ours.
this company does not put out any info. go to this site to see what is said about this POS. Can also use this site to check any pink sheet stock. I have found it useful myself
I have yet to see an article from FDIC or AMCORE about this April 15 rumor. It was a media story by unknown source. They named AMCORE but couldn'y name the other 5 banks. Until this is official you are as bad as the media.Funny how none of you mention May 4 annual meeting. Post what is known as truth not media guessing. I really don't care where stock goes. I'm in for 17500 sh which are now free for me. Bought 35000 sh @ 64 cents last year and sold 17500 sh about a week later for $1.47. I'm not pumping or bashing, just a gamble.
good luck and have a good day.
Did you read where this update was written? The headline doesn't even make sense. They mixed todays earnings report with old news from middle of January and through in the lie they were in default with JPM. I guess it is hard for an Indian reporter in Bangalore, India to tell the truth. This was a meaningless update. I guess ruters will take stories from anybody, whether truthful or not.
Reporting by Brenton Cordeiro in Bangalore; Editing by Unnikrishnan Nair